SHENZHEN,China,Feb. 14,2025-- Kexing Biopharm Co.,Ltd. (Stock Code: 688136.SH) recently announced that the Investigational New Drug Application (IND) of GB05,Human Interferon α1b Inhalation Solution,

SHANGHAI,Feb. 13,2025-- OneConnect Financial Technology Co.,Ltd ("OneConnect" or the "Company",NYSE: OCFT,HKSE: 6638),a business technology service provider for financial instituti

Hanmi Pharmaceutical Global Business Headquarters Accelerates Expansion into Canadian and US Markets,Strengthening Collaboration with Distribution Partner McKesson

SEOUL,South Korea,Feb. 14,2025-- Bellevue Life Sciences Acquisition Corp. ("BLAC") announced today the approval of each of the proposals presented at the special meeting of its stockholders

RIYADH,Saudi Arabia,Feb. 14,2025-- The AlUla Conference for Emerging Market Economies,organized jointly by the Saudi Ministry of Finance and the International Monetary Fund (IMF),kicks off next week

TOKYO,Feb. 13,2025-- Polyplastics Co.,Ltd.,a global leader in engineering plastics,has launched PLASTRON (R) LFT (long fiber-reinforced thermoplastic) RA627P,an eco-friendly composite of polypropylene

BANGKOK,Feb. 13,2025-- Webull Securities (Thailand) Co. Ltd. ("Webull Thailand"),the Thai subsidiary of Webull Corporation ("Webull"),a leading global digital investment platform,

XPOVIO® is the first XPO1 inhibitor approved in Taiwan for the treatment of adult patients with relapsed/refractory multiple myeloma (R/R MM).

HONG KONG,Feb. 14,2025-- Akeso,Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce the acceptance of its Investigational New Drug (IND) application by the China Natio

Champion of the HERO ESPORTS Asian Champions League Honor of Kings tournament will secure a spot at the Esports World Cup